Valeritas sets terms for $75m IPO | Medtech Wall Street news for the week of March 9, 2015

Here's a look at some of the top Wall Street stories for medical device companies this week: Diabetes: Valeritas sets terms for $75m IPO; New Siemens healthcare unit to start in May; Australia halts trading in GI Dynamics shares; Bayer aims to boost drugs sales, margins over next 3 years

Diabetes: Valeritas sets terms for $75m IPO

March 10, 2015 by Brad Perriello

Australian Stock Exchange (ASX), Bayer HealthCare, Siemens, Valeritas Inc., GI Dynamics

News Well, Wall Street Beat

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1FeMz4s